NCT00696033View on ClinicalTrials.gov

Exploring the Effects of Diazepam and Lorazepam

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy Subjects
Interventions
DRUG

Diazepam

Diazépam drug (0,3 mg/kg) on a single oral intake

DRUG

Lorazepam

Lorazépam drug (0,038 mg/kg) on a single oral intake

DRUG

placebo

lorazépam placebo or Diazépam placebo

Trial Locations (2)

67091

Centre d'investigation clinique, hôpital civil, Strasbourg

Clinique psychiatrique, hôpital civil, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT00696033 - Exploring the Effects of Diazepam and Lorazepam | Biotech Hunter | Biotech Hunter